Advertisement

Topics

KCI Licensing, Inc. Company Profile

01:06 EST 10th December 2018 | BioPortfolio

KCI’s innovative therapies make a difference in patients' lives every day. KCI’s therapies can be found helping patients recovering in all care settings. We design, manufacture, market and service a wide range of proprietary products that can improve clinical outcomes while helping to reduce the overall cost of patient care. Our products are backed by a worldwide network of service and clinical support.

Contact

Phone: 1-800-275-4524


News Articles [154 Associated News Articles listed on BioPortfolio]

What Is In-Licensing?

Licensing deals might be pharma’s preferred mode of business development these days—perhaps even more so than outright acquisitions. Read on to find out which pharmaceutical companies have been us...

Nuformix expands licensing agreement with NSB for NXP001

Nuformix has expanded its licensing agreement with its Chinese licensing partner Newsummit Biopharma (NSB) for NXP001, which is being developed...Read More... The post Nuformix expands licensing agree...

Enzychem Lifesciences' Growth Continues in US, Adds Jeff Clark as New Chief Licensing Officer

By serving as Chief Licensing Officer, Dr. Clark will work on strengthening the worldwide Intellectual Property of the company and spearhead global licensing deals and Read more...

Life cycle and regulatory evaluation of biosimilars

The life cycle of a biosimilar, like any biological, starts with research and development, then manufacturing, and is followed by regulatory evaluation of quality, safety and efficacy for both licensi...

Roivant and iNtRON sign licensing deal for SAL200

Roivant Sciences and iNtRON Biotechnology have signed a $667.5m global licensing agreement for SAL200, which is an investigational biologic to...Read More... The post Roivant and iNtRON sign licensing...

United Therapeutics reaches $1.2bn licensing deal with Arena

Biotechnology company United Therapeutics has signed a licensing deal worth up to $1.2bn with biopharmaceutical firm Arena Pharmaceuticals for a...Read More... The post United Therapeutics reaches $1....

Dexcom, Verily amend licensing deal for next-gen CGM system

An amended licensing deal has been reached by Dexcom and Alphabet unit Verily Life Sciences for developing a second-generatio -More- 

Lilly signs licensing and research deal with Dicerna Pharmaceuticals

Eli Lilly has entered a global licensing and research alliance with Dicerna Pharmaceuticals to identify, develop and commercialise potential therapies...Read More... The post Lilly signs licensing and...

Drugs and Medications [0 Results]

None

PubMed Articles [45 Associated PubMed Articles listed on BioPortfolio]

Moral licensing, instrumental apology and insincerity aversion: Taking Immanuel Kant to the lab.

Moral licensing, equivalently called "self-licensing", is the instrumental use of a Good Act to cover up a Bad Act. This paper's thesis is that "instrumental apology" i.e., bad-faith apology, is a cas...

Implementation Strategies Used by States to Support Physical Activity Licensing Standards for Toddlers in Early Care and Education Settings: An Exploratory Qualitative Study.

Child care settings have been a target for childhood obesity prevention efforts; changing licensing standards to require physical activity (PA)-related best practices is one strategy being used by sta...

Compliance with the U.S. Nuclear Regulatory Commission Revised Licensing Guidance for Radioactive Seed Localization.

The use of radioactive seed localization (RSL) as a reliable alternative to wire localization (WL) for guiding the surgical excision of non-palpable lesions has become more popular because of its demo...

'A true partner around the table?' Perceptions of how to strengthen public health's contributions to the alcohol licensing process.

There are increased opportunities for public health practitioners (PHPs) in England to shape alcohol availability and reduce harms through a statutory role in licensing processes in local government. ...

Examining Demographics, Prior Academic Performance, and United States Medical Licensing Examination Scores.

To examine whether demographic differences exist in United States Medical Licensing Examination (USMLE) examination scores and the extent to which any differences are explained by students' prior acad...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

Annual Study for Fluarix Registration

A pre-requisite to the yearly licensing process of the Influenza vaccine (FluarixTM/ Influsplit SSW®) is to demonstrate in clinical studies, the immunogenicity and reactogenicity of the v...

Yearly Strain Variation Study, 2010/2011

The purpose of the study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to WHO/EU recommendation for the 2010/201...

A Post-Marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

Following licensing of PoliorixTM in Korea, this study will collect safety data about the routine use of this vaccine in 600 children according to the regulations of Korean Food and Drugs ...

StaphVAX Immunogenicity in Orthopedic Implant Patients

S. aureus is the most common pathogen involved in prosthetic joint infection. StaphVAX® is a vaccine to prevent these infections, which conjugates the purified capsular polysaccharides of...

Yearly Strain Variation Study, 2009/2010

The purpose of this study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to World Heath Organization/European Uni...

Companies [452 Associated Companies listed on BioPortfolio]

ProPharma Partners (UK)

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new vent...

Propharma Partners Incorporated USA

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new vent...

AllianCat Tschannen - Pharma Research & Licensing Consultants

AllianCat delivers professional support to companies in the pharmaceutical, biotechnology and chemical arena by providing services for business development and licensing. The objective is to optimize ...

Innomedica Ltd

Innomedica Ltd. is an established international business development and licensing company focused on the Life Sciences. Innomedica provides professional services to biotechnology companies in three a...

New Renaissance Institute

New Renaissance Institute® (NRI, www.newrenaissanceinstitute.com) is a privately-held for-profit interdisciplinary R&D institution based in Belmont, California. NRI has innovat...

More Information about "KCI Licensing, Inc." on BioPortfolio

We have published hundreds of KCI Licensing, Inc. news stories on BioPortfolio along with dozens of KCI Licensing, Inc. Clinical Trials and PubMed Articles about KCI Licensing, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KCI Licensing, Inc. Companies in our database. You can also find out about relevant KCI Licensing, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record